غير مصنف

Forward Pharma loses appeal in Tecfidera patent dispute with Biogen

A U.S. federal appeals court on Wednesday upheld a ruling that Biogen Inc’s patents on its blockbuster multiple sclerosis drug Tecfidera are valid, rejecting a challenge by Danish drugmaker Forward Pharma A/S.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى